FluoGuide’s ownership to key patent registered
FluoGuide A/S ("FluoGuide", FLUO), today announces registration of ownership to the key patent family, which was acquired by FluoGuide prior to its IPO in April/May 2019. The patent family was issued nationally in the USA in 2018 and is valid until 2034.FluoGuide’s first product FG001 lights up the cancer and its invasive growth into the surrounding tissue. FG001 is expected to reduce suffering for the patients and increase the likelihood of their cure. It can also reduce costs for the health care system to the benefit of society. FluoGuide focuses on demonstrating the effect of FG001 in